Literature DB >> 21136380

Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells.

Sakthikumar Ambady1, Christopher Malcuit, Olga Kashpur, Denis Kole, William F Holmes, Emmett Hedblom, Raymond L Page, Tanja Dominko.   

Abstract

The transcription factor NANOG is essential for maintaining pluripotency in embryonic stem cells. We have previously reported the expression of NANOG in adult human fibroblasts; here we present a more thorough investigation into the expression of NANOG in a panel of both differentiated and undifferentiated human cells. We utilize RT-PCR, qRT-PCR, cloning and sequencing, sequence alignment, restriction digestion, immunocytochemistry, Western blotting, and EMSA to investigate expression of NANOG in a variety of somatic, transformed and stem cell phenotypes. RT-PCR and qRT-PCR analysis revealed the presence of NANOG transcripts in all the cell types examined, albeit at magnitudes lower than human embryonic stem cells. Further investigation by single nucleotide polymorphism analysis of expressed transcripts in several cell types detected a NANOG pseudogene, NANOGP8, one of only two NANOG pseudogenes with the potential of encoding a similar size protein to embryonic NANOG (eNANOG). Our analysis demonstrates that although the NANOG protein is detected in nearly all cells examined, expression of the eNANOG and/or NANOGP8 transcript as well as the sub-cellular localization of the protein is cell type-specific. Additionally, smooth muscle cells, which express exclusively NANOGP8, display nuclear localization of NANOG protein, indicating that NANOGP8 is a protein coding gene possibly functioning as a transcription factor. Lastly, all cell types expressing eNANOG and/or NANOGP8 were found to be capable of binding a NANOG consensus sequence in vitro. We conclude that eNANOG is not exclusively expressed in undifferentiated cells and that both eNANOG and NANOGP8 may function as transcription factors in a cell type-specific manner.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21136380      PMCID: PMC4623431          DOI: 10.1387/ijdb.103192sa

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  48 in total

1.  NANOGP8 is a retrogene expressed in cancers.

Authors:  Jingyu Zhang; Xia Wang; Meixiang Li; Jin Han; Bing Chen; Bin Wang; Jianwu Dai
Journal:  FEBS J       Date:  2006-04       Impact factor: 5.542

2.  A genome-wide survey of human pseudogenes.

Authors:  David Torrents; Mikita Suyama; Evgeny Zdobnov; Peer Bork
Journal:  Genome Res       Date:  2003-12       Impact factor: 9.043

3.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

4.  The POU5F1P1 pseudogene encodes a putative protein similar to POU5F1 isoform 1.

Authors:  Ioannis Panagopoulos; Emely Möller; Anna Collin; Fredrik Mertens
Journal:  Oncol Rep       Date:  2008-11       Impact factor: 3.906

5.  Nanog expression in mouse germ cell development.

Authors:  Shinpei Yamaguchi; Hironobu Kimura; Masako Tada; Norio Nakatsuji; Takashi Tada
Journal:  Gene Expr Patterns       Date:  2005-04-09       Impact factor: 1.224

Review 6.  The homeodomain protein Nanog and pluripotency in mouse embryonic stem cells.

Authors:  A Yates; I Chambers
Journal:  Biochem Soc Trans       Date:  2005-12       Impact factor: 5.407

7.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

8.  Chromatin states of core pluripotency-associated genes in pluripotent, multipotent and differentiated cells.

Authors:  Sanna Barrand; Philippe Collas
Journal:  Biochem Biophys Res Commun       Date:  2009-11-26       Impact factor: 3.575

9.  Expression of pluripotent stem cell markers in the human fetal testis.

Authors:  Candace L Kerr; Christine M Hill; Paul D Blumenthal; John D Gearhart
Journal:  Stem Cells       Date:  2007-11-15       Impact factor: 6.277

10.  Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation.

Authors:  Fang Wei; Hans R Schöler; Michael L Atchison
Journal:  J Biol Chem       Date:  2007-05-24       Impact factor: 5.157

View more
  22 in total

1.  Nanog increases focal adhesion kinase (FAK) promoter activity and expression and directly binds to FAK protein to be phosphorylated.

Authors:  Baotran Ho; Gretchen Olson; Sheila Figel; Irwin Gelman; William G Cance; Vita M Golubovskaya
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

2.  Maintenance of multipotency in human dermal fibroblasts treated with Xenopus laevis egg extract requires exogenous fibroblast growth factor-2.

Authors:  Denis Kole; Sakthikumar Ambady; Raymond L Page; Tanja Dominko
Journal:  Cell Reprogram       Date:  2014-01-03       Impact factor: 1.987

Review 3.  Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions.

Authors:  Collene R Jeter; Tao Yang; Junchen Wang; Hsueh-Ping Chao; Dean G Tang
Journal:  Stem Cells       Date:  2015-05-13       Impact factor: 6.277

4.  Transcription factor decoy against stem cells master regulators, Nanog and Oct-4: a possible approach for differentiation therapy.

Authors:  Seyed Mohammad Ali Hosseini Rad; Taravat Bamdad; Majid Sadeghizadeh; Ehsan Arefian; Majid Lotfinia; Milad Ghanipour
Journal:  Tumour Biol       Date:  2014-12-03

5.  Characterization of the Nanog gene involved in the gonadal development in pearlscale angelfish (Centropyge vrolikii).

Authors:  Zhaowei Zhong; Yan Xu; Yan Feng; Lulu Ao; Yonghua Jiang
Journal:  Fish Physiol Biochem       Date:  2022-02-09       Impact factor: 2.794

Review 6.  The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells.

Authors:  Natalia Gawlik-Rzemieniewska; Ilona Bednarek
Journal:  Cancer Biol Ther       Date:  2016       Impact factor: 4.742

7.  The pluripotency factor Nanog is directly upregulated by the androgen receptor in prostate cancer cells.

Authors:  Steven Kregel; Russell Z Szmulewitz; Donald J Vander Griend
Journal:  Prostate       Date:  2014-08-31       Impact factor: 4.104

8.  NANOG modulates stemness in human colorectal cancer.

Authors:  J Zhang; L A Espinoza; R J Kinders; S M Lawrence; T D Pfister; M Zhou; T D Veenstra; S S Thorgeirsson; J M Jessup
Journal:  Oncogene       Date:  2012-10-22       Impact factor: 9.867

Review 9.  Pluripotency transcription factors in lung cancer-a review.

Authors:  Sylwia Sławek; Krzysztof Szmyt; Maciej Fularz; Joanna Dziudzia; Maciej Boruczkowski; Jan Sikora; Mariusz Kaczmarek
Journal:  Tumour Biol       Date:  2015-11-18

10.  NANOGP8: evolution of a human-specific retro-oncogene.

Authors:  Daniel J Fairbanks; Aaron D Fairbanks; T Heath Ogden; Glendon J Parker; Peter J Maughan
Journal:  G3 (Bethesda)       Date:  2012-11-01       Impact factor: 3.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.